Behzad Hatami is an expert in Gastroenterology at Shahid Beheshti University of Medical Sciences (Iran). As of October 2026, ScienceLeadR ranks Behzad Hatami in the top 1% of experts in Iran for Liver Cirrhosis. Behzad Hatami has authored 99 publications, the most recent in 2026, and is an investigator in 1 clinical trial, 1 of them ongoing. SLR score: 298 (community average: 125). How the SLR is computed.

LeadR Profile

298 ScienceLeadR Reputation 298
Network Map

Gastroenterology

Subspecialties: Pharmacy - Hepatology - Nutrition

Full career – Last 3 years

Main Topics

Publications and Clinical Studies

Publications – Clinical Studies

Profile data updated on

Expert Rankings

Top experts on the MeSH terms this expert works on

Organizations

Career arc: 2016 - 2026

Source: PubMed

Shahid Beheshti University of Medical Sciences

Publications Synthesis

Sources: PubMed, OpenAlex

Number : 99

Citations

Citations: 970 1st author: 12 Last author: 6 Unique author: 0


Best Journals

Breakdown by type

Click a legend label to hide or show it in the chart.

Latest Publications

5 most recent indexed articles

Source: Pubmed

Title Journal Year Citations
Association between dietary fatty acids and all-cause mortality in patients with cirrhosis: A cohort study.
PMID 42804465 — physiology, mortality, liver cirrhosis, cohort studies, diet, fatty acids
Exp Physiol20260
Metabolic ketosis attenuates NLRP3 inflammasome activation and is associated with improvements in hepatic steatosis and liver stiffness in MASLD: a pilot randomized controlled trial.
PMID 42546517 — registries, pilots, inflammasomes, liver, caspases, adipokines, ketosis, liver stiffness
Int Immunopharmacol20260
The Association of Dietary Macronutrient Quality and Mortality Among Patients With Liver Cirrhosis: A Prospective Cohort Study.
PMID 42534380 — mortality, liver cirrhosis, cohort studies, liver
Health Sci Rep20260
Early Posttransplant Lymphoproliferative Disorder and Cryptosporidiosis After Liver Transplantation.
PMID 42183336 — liver transplantation, lymphoma, large b-cell, diffuse, liver, signs and symptoms, herpesvirus 4, human, cryptosporidiosis, diagnosis, transplants, therapeutics, lymphoproliferative disorders, diarrhea, immunosuppression therapy, transplantation, infections
Case Rep Med20260
The Effects of Flaxseed Consumption on Frailty and Sarcopenia in Patients With Liver Cirrhosis: An Open-Labeled Randomized Controlled Clinical Trial.
PMID 41473401 — muscles, liver cirrhosis, c-reactive protein, body composition, liver, muscle strength, frailty, sarcopenia
Food Sci Nutr20250

Clinical Studies 1

Sources: ClinicalTrials, EU CTIS

Synthesis

Principal Investigator: 1

By phase:

Phase 2 1

By status:

Recruiting 1

By type:

Interventional 1

By Monocentric/Multicentric:

monocentric 1
multicentric2to4 0
multicentric5to9 0
multicentricup10 0

Main Topics

Ongoing Clinical Trials

Ongoing trial started since 2021, where this expert is an investigator

Source: ClinicalTrials

Study Phase Status Start
Effect of Mesenchymal Stem Cells derived Exosomes in Decompensated Liver Cirrhosis
NCT05871463 — cells, hemorrhage, microscopy, electron, scanning transmission, liver cirrhosis, fibrosis, pharmaceutical preparations, stem cells, mesenchymal stem cells, liver, exosomes, brain diseases, therapeutics, hepatitis b, hepatic encephalopathy, hepatitis, ascites
Phase 2Recruiting2023

LeadR Networks

Main global connection map